NRMI and current treatment patterns for ST-elevation myocardial infarction

Am Heart J. 2004 Nov;148(5 Suppl):S29-33. doi: 10.1016/j.ahj.2004.09.012.

Abstract

The National Registry of Myocardial Infarction (NRMI) is one of the oldest and largest registries of acute myocardial infarction (AMI). Since 1990, 4 NRMI studies have been launched, one of which is ongoing (Table I). In all, 1600 hospitals have participated and >2.2 million patients have been followed. This paper highlights some of our discoveries pertaining to ST-segment elevation and subsequent contributions to patient care.

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Angioplasty, Balloon, Coronary / statistics & numerical data*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Aspirin / therapeutic use
  • Electrocardiography
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Myocardial Infarction / mortality
  • Myocardial Infarction / therapy*
  • Randomized Controlled Trials as Topic
  • Registries*
  • United States

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Fibrinolytic Agents
  • Aspirin